Is CBD legal in the United States? Yes — hemp-derived CBD that contains less than 0.3% THC by dry weight is federally legal under the 2018 Farm Bill. State laws, however, vary significantly. And while research suggests CBD may support discomfort, anxiety, and sleep for some adults, the U.S. Food and Drug Administration has not approved CBD as a treatment for any condition outside of one prescription drug for rare seizure disorders.
If you have searched online for clarity on CBD benefits or whether you can legally buy CBD in your state, you have probably come away more confused than when you started. Most articles either oversell the science ("CBD cures everything") or undersell the law ("CBD is illegal everywhere"). Both are wrong, and both are unhelpful.
This guide is the plain-English version. We walk through what CBD is, what current research actually suggests it may do, the federal legal framework, the patchwork of state rules in 2026, and what to look for in a quality product. It is the same information we share with our customers in Casper, Wyoming.
Why this matters: clarity is in short supply
CBD is a multibillion-dollar U.S. category, but consumer information lags behind sales. The FDA continues to issue warning letters to brands making unsubstantiated health claims. The USDA has built out a federal hemp program. State legislatures have rewritten their hemp laws in 2024 and 2025 to address intoxicating hemp-derived cannabinoids — most notably Delta-8 THC and certain hemp-derived Delta-9 products.
For consumers, the result is that the rules in your state may be very different from the rules in your neighbor's state. For brands, the result is real legal exposure for any company that overstates benefits or sells into restricted states. Understanding the framework is the difference between a confident, informed purchase and a guess.
What CBD is, and where it comes from
Cannabidiol (CBD) is one of more than 100 cannabinoids identified in the cannabis plant. The two most well-known are CBD and tetrahydrocannabinol (THC). THC is intoxicating; CBD is not. Both interact with the body's endocannabinoid system (ECS), but they bind to its receptors very differently.
Two distinct legal products come from the same plant family. Hemp is cannabis bred to contain less than 0.3% THC by dry weight, which is the federal cutoff defined by the 2018 Farm Bill. Marijuana is cannabis above that THC cutoff. Hemp-derived CBD is federally legal; marijuana-derived CBD is federally restricted (though legal in many state-level adult-use and medical programs).
Full-spectrum, broad-spectrum, and isolate — what's the difference?
Three product types dominate the CBD aisle. They differ in which compounds from the hemp plant are kept in the final product.
|
Product type |
What's in it |
Best for |
Drug-test risk |
|
Full-spectrum |
CBD + minor cannabinoids + terpenes + trace THC (≤0.3%) |
Adults wanting the full hemp profile ("entourage effect") |
Higher — trace THC may register on screens |
|
Broad-spectrum |
CBD + minor cannabinoids + terpenes; THC removed (typically non-detectable) |
Adults who want hemp's full profile minus THC |
Low — confirm via Certificate of Analysis |
|
CBD isolate |
Pure CBD only (typically 99%+ CBD) |
Adults sensitive to other cannabinoids; targeted use |
Lowest — no detectable THC |
If you are subject to drug testing — workplace, athletic governing body, or court — choose broad-spectrum or isolate, and confirm "non-detectable" THC on the Certificate of Analysis.
What the research actually suggests CBD may do
Honest framing: the CBD evidence base is growing but still limited. Most adult use cases are supported by small clinical trials, animal studies, and survey data — not the large randomized trials the FDA typically relies on for new drug approvals. Here is a fair summary of what the science currently suggests, and where the limits are.
Pain and discomfort
A 2018 review in Frontiers in Pharmacology summarized current evidence on cannabinoids and pain, concluding that CBD and cannabis-based medicines may support pain management for some adults, particularly when conventional approaches fall short. This is not a claim that CBD treats chronic pain — and the FDA has not approved any CBD product for that purpose.
Joints and inflammation
A 2016 study in the European Journal of Pain examined topical CBD in an animal model of arthritis and reported reduced inflammation and pain-related behaviors. Animal models are useful starting points, not substitutes for human clinical trials. The Arthritis Foundation has acknowledged anecdotal reports of CBD's perceived benefits while emphasizing that more research is needed.
Anxiety and stress
A 2019 case series published in The Permanente Journal followed adults with anxiety or sleep concerns who used CBD for several months. About 79% of participants reported decreased anxiety scores within the first month. Case series are observational, not controlled trials, but the signal is consistent with other early evidence on CBD and stress.
Sleep
A 2017 review in Current Psychiatry Reports examined cannabinoids and sleep, concluding that CBD may show promise for sleep concerns, particularly when those concerns are tied to anxiety. The research is short-term in scope, and chronic-use data is still limited.
Seizure disorders (the only FDA-approved use)
The FDA has approved Epidiolex, a purified CBD prescription drug, to treat seizures associated with rare conditions including Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. This is the only FDA-approved CBD drug. It is a prescription product — not the same as the CBD products sold over the counter.
Federal legal framework: the 2018 Farm Bill and three agencies
The 2018 Farm Bill (formally the Agriculture Improvement Act of 2018) is the foundation of the modern hemp and CBD industry. It removed hemp from the Controlled Substances Act, legalized hemp cultivation, and authorized interstate commerce in hemp-derived products that contain less than 0.3% THC by dry weight. Three federal agencies share oversight.
U.S. Food and Drug Administration (FDA)
The FDA regulates CBD in food, beverages, dietary supplements, and cosmetics. As of early 2026, the FDA has approved CBD only as the prescription drug Epidiolex. The agency does not currently recognize CBD as a dietary supplement, and it routinely issues warning letters to brands making disease-treatment claims. Labels must follow FDA guidelines for ingredient disclosure, dosage instructions, and claim substantiation.
Drug Enforcement Administration (DEA)
Hemp-derived CBD is not a controlled substance under federal law. Marijuana-derived CBD remains Schedule I. The DEA's enforcement focus has shifted toward intoxicating cannabinoids derived from hemp — including some forms of Delta-8 and synthetically produced cannabinoids — and toward THC content over the federal 0.3% threshold.
U.S. Department of Agriculture (USDA)
The USDA oversees hemp cultivation under federal and state hemp production plans. It also operates the National Organic Program, which sets the standards behind the USDA Organic seal. Soothe Organic's hemp is grown to USDA Certified Organic standards — meaning no synthetic pesticides, no GMO seed, and full traceability through the supply chain.
Image Source: https://worldpopulationreview.com/state-rankings/cbd-legal-state
The state-by-state patchwork in 2026
Federal legality does not preempt state regulation. Every state has its own framework for hemp and CBD — and several states tightened their rules in 2024 and 2025, particularly around intoxicating hemp-derived cannabinoids. Rather than publish a state-by-state list that risks being out of date the moment it is published, here is the practical framework consumers and brands should use.
Three broad categories
Most states fall into one of three groups. The exact category for your state can change with a single legislative session, so always confirm with your state's department of agriculture or attorney general's office.
- Broadly aligned with federal law. Hemp-derived CBD with less than 0.3% THC is widely available; sales channels include retail, online, and mainstream grocery. Examples have historically included California, Colorado, New York, and Illinois — though all of these have layered additional rules in recent years, particularly on intoxicating hemp products.
- Conditionally legal. CBD is legal under specific conditions — typically a strict THC cap, a labeling and testing regime, or a registration requirement for sellers. Examples have included Texas, Florida, and Georgia. Several of these states have moved to restrict hemp-derived intoxicants since 2024.
- Restricted. A small number of states maintain stricter rules, sometimes limiting CBD to FDA-approved products (Epidiolex) or imposing significant labeling and licensing requirements. Examples have historically included Idaho and South Dakota.
If you ship products across state lines, you are responsible for understanding the destination state's rules. The National Conference of State Legislatures maintains a regularly updated state cannabis-laws tracker, which is a reasonable starting point but should not substitute for direct confirmation with state regulators or counsel.
How to evaluate a CBD product, step by step
Whether you are buying for yourself or sourcing for a business, the same checklist applies.
- Confirm the source. Look for U.S.-grown hemp, ideally USDA Certified Organic. Imported hemp can be fine, but the supply chain is harder to verify.
- Look for a public Certificate of Analysis from an accredited third-party lab. The COA should match the batch number on the bottle and should test for potency (CBD content), residual solvents, pesticides, heavy metals, and microbials.
- Check the THC level. For broad-spectrum or isolate products, the COA should show non-detectable (ND) THC. If you are drug-tested, full-spectrum is a risk.
- Read the label. The label should disclose CBD content per serving, total CBD per package, full ingredient list, and clear dosing instructions. Vague labels ("hemp extract") with no milligram disclosure are a red flag.
- Ignore disease claims. Any CBD product that claims to "cure cancer," "treat Alzheimer's," or "prevent disease" is making an FDA-prohibited claim. That is a sign to walk away — both from the product and the brand.
- Check state legality. Confirm the product is legal where you live and where it will be shipped. Both consumer and brand are responsible for compliance.
If you operate a CBD business: the practical checklist
Operating a hemp-CBD business in 2026 means staying current with a moving regulatory target. The basics:
- Licensing. Requirements vary by state and by activity. Cultivation, processing, manufacturing, retail, and transportation are typically licensed separately. Confirm with your state department of agriculture and any applicable municipal regulators.
- Labeling. Federal and state labeling rules cover claim language, ingredient disclosure, THC content, and required disclaimers. Several states require batch-specific QR codes that link to lab reports.
- Marketing. Substantiate every claim. The FDA, FTC, and state attorneys general have all taken action against hemp-CBD brands for unsupported claims. Avoid disease-treatment language even in social media and email.
- Ad platforms. Meta and Google have specific (and frequently changing) policies on CBD advertising. Most CBD ad creative is reviewed manually and rejected for any health-claim language.
- Banking and payments. Many U.S. banks and payment processors will work with hemp-CBD businesses, but underwriting standards vary widely. Have backup processors lined up before launch.
- Interstate commerce. Federal law permits interstate sale of hemp-derived CBD, but state laws control what can be shipped into a given state. Maintain a current list of restricted destinations and update at least quarterly.
How Soothe Organic stays compliant — and why it matters to you
Soothe Organic was started by a Wyoming family that refused to settle for hemp products built on synthetic shortcuts. Every product we ship is rooted in three commitments:
- USDA Certified Organic hemp grown without synthetic pesticides or GMO seed.
- Independent third-party lab testing on every batch — Certificates of Analysis are public on our site.
- Compliance-first labeling. We disclose CBD content per serving, total CBD, full ingredients, and clear dosing — and we do not make disease claims.
If you want to start with one of our most popular formats, see our CBD tinctures or our CBD edibles. You can also read our Wyoming story for more on how we got here.
Related reading
- U.S. Food and Drug Administration — current regulatory position on CBD.
- U.S. Department of Agriculture — federal hemp production rules.
- National Conference of State Legislatures — state cannabis-laws tracker.
- National Center for Complementary and Integrative Health — current research on CBD safety and effectiveness.
- Soothe Organic — companion guides on CBD dosage for sleep and CBD for muscle recovery.
Frequently asked questions
Is CBD legal in all 50 states?
Hemp-derived CBD with less than 0.3% THC is federally legal under the 2018 Farm Bill, but state laws vary significantly. Some states have additional rules around labeling, testing, sales channels, and intoxicating hemp-derived cannabinoids. Always confirm your state's current rules before purchasing or shipping.
Will CBD make me feel high?
No. CBD is not intoxicating. Hemp-derived CBD products contain less than 0.3% THC by dry weight, and broad-spectrum and isolate products are formulated to be THC-free. You should not feel impaired.
Will CBD show up on a drug test?
Pure CBD does not show up on standard workplace drug screens, but full-spectrum products contain trace THC that can occasionally trigger a positive result with regular use. If you are tested, choose a broad-spectrum or isolate product and confirm the third-party Certificate of Analysis shows non-detectable THC.
Has the FDA approved any CBD products?
Yes — but only one. Epidiolex, a purified prescription CBD drug, is FDA-approved to treat seizures associated with three rare conditions. No over-the-counter CBD product is FDA-approved as a dietary supplement, and the FDA actively warns brands that make disease-treatment claims.
What should I look for on a Certificate of Analysis?
A good COA matches the batch number on the bottle and tests for cannabinoid potency, residual solvents, pesticides, heavy metals, and microbials. It should be from an accredited third-party lab — not the brand's own internal testing. If a brand will not share its COAs, do not buy from that brand.
A final word from Casper, Wyoming
CBD's legal landscape is not as scary as it looks — once you know the framework. Federal law sets the floor (hemp-derived CBD with less than 0.3% THC). State law sets the ceiling. Quality varies wildly across brands, but a public Certificate of Analysis is the universal signal of a brand worth buying. Disease claims are the universal signal of a brand to avoid.
When you are ready to try a USDA Certified Organic, third-party-tested option, see our full CBD lineup. Use code SOOTHE25 for 25% off your first order. Refuse to settle. Defy the odds. Leave it better than you found it.
Important disclaimer
This article is for educational purposes only and is not medical, legal, or financial advice. Soothe Organic is not a medical clinic or a law firm. Statements about our products have not been evaluated by the U.S. Food and Drug Administration. Our CBD products are not intended to diagnose, treat, cure, or prevent any disease. Hemp-derived CBD products are federally legal under the 2018 Farm Bill when below 0.3% THC by dry weight, but state laws vary and can change without notice. Talk to your healthcare provider before starting any new supplement, and consult a qualified attorney before relying on any part of this article for compliance, business, or interstate-commerce decisions.
